Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany

被引：23
作者：
Fluegge, K
Supper, S
Siedler, A
Berner, R
机构：
[1] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany
[2] Robert Koch Inst, D-1000 Berlin, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 11期
关键词：
D O I：
10.1128/AAC.48.11.4444-4446.2004
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The antimicrobial susceptibility of 296 invasive neonatal group B streptococcus isolates from a nationwide 2-year surveillance study in Germany was investigated. All isolates were susceptible to beta-lactams, linezolid, quinupristin-dalfopristin, and vancomycin. Erythromycin and clindamycin resistance was found in 10.1 and 5.7%, respectively. The ermB, ermTR, or mefA gene was detected in all but one of the erythromycin-resistant isolates.
引用
收藏
页码：4444 / 4446
页数：3
相关论文
共 31 条
[1]   ANTIBIOTIC-RESISTANCE AND PENICILLIN TOLERANCE IN CLINICAL ISOLATES OF GROUP-B STREPTOCOCCI [J].
BETRIU, C ;
GOMEZ, M ;
SANCHEZ, A ;
CRUCEYRA, A ;
ROMERO, J ;
PICAZO, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :2183-2186
[2]   Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae [J].
Betriu, C ;
Culebras, E ;
Gómez, M ;
Rodríguez-Avial, I ;
Sánchez, BA ;
Agreda, MC ;
Picazo, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1112-1114
[3]   Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].
Bingen, E ;
Fitoussi, F ;
Doit, C ;
Cohen, R ;
Tanna, A ;
George, R ;
Loukil, C ;
Brahimi, N ;
Le Thomas, I ;
Deforche, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457
[4]   HIGH-LEVEL CHROMOSOMAL GENTAMICIN RESISTANCE IN STREPTOCOCCUS-AGALACTIAE (GROUP-B) [J].
BUUHOI, A ;
LEBOUGUENEC, C ;
HORAUD, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :985-988
[5]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[6]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[7]   Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae [J].
Culebras, E ;
Rodriguez-Avial, I ;
Betriu, C ;
Redondo, M ;
Picazo, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1574-1576
[8]   Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada [J].
de Azavedo, JCS ;
McGavin, M ;
Duncan, C ;
Low, DE ;
McGeer, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3504-3508
[9]   Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae:: French multicenter study [J].
De Mouy, D ;
Cavallo, JD ;
Leclercq, R ;
Fabre, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2400-2402
[10]  
*DTSCH I NORM, METH EMPF MIKR KRANH
1234